Cytosorbents Cor (CTSO) 7.52 $CTSO
Premarket Gainers / Losers as of 9:15 am
Seeking Alpha - at Seeking Alpha - Fri Apr 24, 8:17AM CDT
AMZN: 445.10 (+55.11), EMES: 44.65 (-5.95), ANY: 4.08 (-0.19), DDD: 27.23 (-2.92), AERI: 12.87 (-22.52), INFY: 31.81 (-3.15), NBG: 1.23 (+0.06), VLTC: 11.54 (+0.50), TRIL: 24.21 (+2.05), JNPR: 26.14 (+2.14), AMCN: 4.95 (-0.05), AMSC: 6.88 (-3.12), UEC: 2.31 (-0.09), LOOK: 1.97 (+0.37), CTSO: 7.52 (+0.50), RMD: 65.70 (-7.68), SSYS: 51.28 (-3.29), LPCN: 6.85 (-0.27), HMHC: 24.21 (-0.13), MSFT: 47.87 (+4.53), EHTH: 13.50 (+2.06)
CytoSorbents Issues Letter to Shareholders
PR Newswire - Fri Apr 24, 7:00AM CDT
CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy company commercializing its European Union approved CytoSorb® blood filter to treat deadly inflammation in critically-ill and cardiac surgery patients, issued a letter to its shareholders as part of its annual report, from its Chief Executive Officer, Dr. Phillip Chan, which reads as follows:
CTSO: 7.52 (+0.50)
Nasdaq stocks posting largest percentage decreases
AP - Tue Apr 14, 4:58PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
PFPT: 54.33 (-2.60), ARWR: 7.28 (+0.05), ASPS: 23.24 (+0.76), CTSO: 7.52 (+0.50), SCYX: 9.47 (-0.52), FOMX: 10.46 (-0.44), AKBA: 8.67 (-0.08), TGLS: 11.72 (-0.08), EXA: 11.82 (+0.30), SPKE: 13.00 (-0.04)
CytoSorbents to Present at the 14th Annual Needham Healthcare Conference
PR Newswire - Tue Apr 14, 6:00AM CDT
CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy company using blood purification to treat deadly inflammation in critically-ill and cardiac surgery patients, announced that Dr. Phillip Chan, MD, PhD, Chief Executive Officer of CytoSorbents, will make a corporate presentation at the 14th Annual Needham Healthcare Conference at the Westin NY Grand Central Hotel in New York City, New York.
CTSO: 7.52 (+0.50)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Mon Apr 13, 11:44AM CDT
NPD: 3.18 (+0.22), TEAR: 2.44 (-0.02), UQM: 1.04 (unch), ASPS: 23.24 (+0.76), CPHR: 11.30 (+0.01), SYRX: 2.25 (-0.09), CHOP: 3.41 (-0.20), NTLS: 5.42 (-0.15), HKTV: 9.11 (+1.44), PME: 1.88 (-0.06), CALI: 2.28 (-0.05), GBSN: 4.17 (-0.53), CTSO: 7.52 (+0.50), ORMP: 7.45 (+0.08), CYTX: 0.99 (+0.01), EXA: 11.82 (+0.30), BAS: 8.70 (+0.62), ENRJ: 1.70 (+0.03), BLDR: 12.79 (-0.09), REPH: 11.88 (+1.04)
CytoSorbents Issues Responses to Frequently Asked Questions
PR Newswire - Tue Apr 07, 7:01AM CDT
CytoSorbents Corporation (NASDAQ CM: CTSO), a critical care immunotherapy company using blood purification to treat critically-ill and cardiac surgery patients in multiple countries worldwide, has prepared a list of Frequently Asked Questions ("FAQs"
in response to shareholder inquiries following its 2014 Year End Earnings Call on March 31, 2015. A full transcript of the earnings call is available on the Company's website, here.
CTSO: 7.52 (+0.50)
CytoSorbents plunges on soft direct sales guidance
Seeking Alpha - at Seeking Alpha - Wed Apr 01, 12:43PM CDT
CTSO: 7.52 (+0.50)
Why Cytosorbents Corp Shares Burst Today
Todd Campbell, The Motley Fool - Motley Fool - Wed Apr 01, 12:32PM CDT
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares in Cytosorbents Corp collapsed...
CTSO: 7.52 (+0.50)
Cytosorbents ups revenues 71% in FY14
Seeking Alpha - at Seeking Alpha - Wed Apr 01, 5:34AM CDT
CTSO: 7.52 (+0.50)
Cytosorbents reports FY'14 results
Seeking Alpha - at Seeking Alpha - Tue Mar 31, 3:55PM CDT
CTSO: 7.52 (+0.50)
Premarket Gainers / Losers as of 9:15 am
Seeking Alpha - at Seeking Alpha - Fri Apr 24, 8:17AM CDT
AMZN: 445.10 (+55.11), EMES: 44.65 (-5.95), ANY: 4.08 (-0.19), DDD: 27.23 (-2.92), AERI: 12.87 (-22.52), INFY: 31.81 (-3.15), NBG: 1.23 (+0.06), VLTC: 11.54 (+0.50), TRIL: 24.21 (+2.05), JNPR: 26.14 (+2.14), AMCN: 4.95 (-0.05), AMSC: 6.88 (-3.12), UEC: 2.31 (-0.09), LOOK: 1.97 (+0.37), CTSO: 7.52 (+0.50), RMD: 65.70 (-7.68), SSYS: 51.28 (-3.29), LPCN: 6.85 (-0.27), HMHC: 24.21 (-0.13), MSFT: 47.87 (+4.53), EHTH: 13.50 (+2.06)
CytoSorbents Issues Letter to Shareholders
PR Newswire - Fri Apr 24, 7:00AM CDT
CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy company commercializing its European Union approved CytoSorb® blood filter to treat deadly inflammation in critically-ill and cardiac surgery patients, issued a letter to its shareholders as part of its annual report, from its Chief Executive Officer, Dr. Phillip Chan, which reads as follows:
CTSO: 7.52 (+0.50)
Nasdaq stocks posting largest percentage decreases
AP - Tue Apr 14, 4:58PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
PFPT: 54.33 (-2.60), ARWR: 7.28 (+0.05), ASPS: 23.24 (+0.76), CTSO: 7.52 (+0.50), SCYX: 9.47 (-0.52), FOMX: 10.46 (-0.44), AKBA: 8.67 (-0.08), TGLS: 11.72 (-0.08), EXA: 11.82 (+0.30), SPKE: 13.00 (-0.04)
CytoSorbents to Present at the 14th Annual Needham Healthcare Conference
PR Newswire - Tue Apr 14, 6:00AM CDT
CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy company using blood purification to treat deadly inflammation in critically-ill and cardiac surgery patients, announced that Dr. Phillip Chan, MD, PhD, Chief Executive Officer of CytoSorbents, will make a corporate presentation at the 14th Annual Needham Healthcare Conference at the Westin NY Grand Central Hotel in New York City, New York.
CTSO: 7.52 (+0.50)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Mon Apr 13, 11:44AM CDT
NPD: 3.18 (+0.22), TEAR: 2.44 (-0.02), UQM: 1.04 (unch), ASPS: 23.24 (+0.76), CPHR: 11.30 (+0.01), SYRX: 2.25 (-0.09), CHOP: 3.41 (-0.20), NTLS: 5.42 (-0.15), HKTV: 9.11 (+1.44), PME: 1.88 (-0.06), CALI: 2.28 (-0.05), GBSN: 4.17 (-0.53), CTSO: 7.52 (+0.50), ORMP: 7.45 (+0.08), CYTX: 0.99 (+0.01), EXA: 11.82 (+0.30), BAS: 8.70 (+0.62), ENRJ: 1.70 (+0.03), BLDR: 12.79 (-0.09), REPH: 11.88 (+1.04)
CytoSorbents Issues Responses to Frequently Asked Questions
PR Newswire - Tue Apr 07, 7:01AM CDT
CytoSorbents Corporation (NASDAQ CM: CTSO), a critical care immunotherapy company using blood purification to treat critically-ill and cardiac surgery patients in multiple countries worldwide, has prepared a list of Frequently Asked Questions ("FAQs"
in response to shareholder inquiries following its 2014 Year End Earnings Call on March 31, 2015. A full transcript of the earnings call is available on the Company's website, here. CTSO: 7.52 (+0.50)
CytoSorbents plunges on soft direct sales guidance
Seeking Alpha - at Seeking Alpha - Wed Apr 01, 12:43PM CDT
CTSO: 7.52 (+0.50)
Why Cytosorbents Corp Shares Burst Today
Todd Campbell, The Motley Fool - Motley Fool - Wed Apr 01, 12:32PM CDT
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares in Cytosorbents Corp collapsed...
CTSO: 7.52 (+0.50)
Cytosorbents ups revenues 71% in FY14
Seeking Alpha - at Seeking Alpha - Wed Apr 01, 5:34AM CDT
CTSO: 7.52 (+0.50)
Cytosorbents reports FY'14 results
Seeking Alpha - at Seeking Alpha - Tue Mar 31, 3:55PM CDT
CTSO: 7.52 (+0.50)
